"Bacterial Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
| Descriptor ID |
D001428
|
| MeSH Number(s) |
D20.215.894.135
|
| Concept/Terms |
Bacterial Vaccines- Bacterial Vaccines
- Vaccine, Bacterial
- Bacterin
- Bacterial Vaccine
- Vaccines, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Bacterial Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Bacterial Vaccines".
This graph shows the total number of publications written about "Bacterial Vaccines" by people in this website by year, and whether "Bacterial Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 12 | 8 | 20 |
| 2018 | 14 | 7 | 21 |
| 2019 | 6 | 3 | 9 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bacterial Vaccines" by people in Profiles.
-
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. Elife. 2021 07 13; 10.
-
COVID-19 vaccine and boosted immunity: Nothing ad interim to do? Vaccine. 2020 11 10; 38(48):7581-7584.
-
Is the production of a Covid-19 vaccine using transformed Pasteurella plausible? Vet Rec. 2020 07; 187(1):e2.
-
Targeting Glycans on Human Pathogens for Vaccine Design. Curr Top Microbiol Immunol. 2020; 428:129-163.
-
Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage. J Infect Dis. 2019 10 08; 220(10):1589-1598.
-
Microbial epidemiology and carriage studies for the evaluation of vaccines. J Med Microbiol. 2019 Oct; 68(10):1408-1418.
-
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2019 10; 19(10):1091-1100.
-
Computational design of a chimeric epitope-based vaccine to protect against Staphylococcus aureus infections. Mol Cell Probes. 2019 08; 46:101414.
-
Alternatives to antibiotics in an era of difficult-to-treat resistance: new insights. Expert Rev Clin Pharmacol. 2019 Jul; 12(7):635-642.
-
Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA. J Control Release. 2019 06 28; 304:65-74.